Investment / SSI Diagnostica

Infectious disease IVD company focused on gastrointestinal, respiratory and bloodborne disease diagnostics and vaccine quality control

About SSI Diagnostica

SSI Diagnostica is a global infectious disease IVD company focusing on gastrointestinal, respiratory and bloodborne diseases. The company focuses on rapid diagnostic tests, QC testing for vaccine products, antisera, and several other in vitro diagnostic products.

For more information, please visit www.ssidiagnostica.com.

Press releases

Adelis acquires SSI Diagnostica from the State of Denmark in privatization process
30 March 2016
SSI Diagnostica acquires US-based CTK Biotech, creating global rapid diagnostics powerhouse
26 August 2020
Adelis Equity Partners raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition
22 August 2022